A Phase IIIb Study to Evaluate the Safety and Efficacy of Gemigliptin in Type 2 Diabetes Mellitus Patients With Moderate or Severe Renal Impairment(GUARD Study)
Clinical trial NCT01968044 · COMPLETED
Trial details
- NCT number
- NCT01968044
- Sponsor
- LG Life Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-10-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.